NL-OMON48911
Completed
Not Applicable
A single-center, randomized, double-blind, placebo-controlled, parallel-group studie investigating the safety, tolerability and pharmacokinetics of single- and multiple-ascending subcutaneous doses of TA-46 in healthy volunteers - TA-46 SAD and MAD dose study to investigate safety and PK
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Achondroplasia
- Sponsor
- Therachon SAS
- Enrollment
- 102
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- healthy male or female subjects
- •\- female volunteers sterilized or post\-memopausal
- •\- 21\-55 yrs, inclusive
- •\- BMI: 18\.0\-28\.0 kg/m2, inclusive
- •\- non\-smoking or light smokers (smoking not allowed in clinic)
Exclusion Criteria
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of
- •participation in another drug study within 90 days before the start of this
- •study or being a blood donor within 60 days from the start of the study. In
- •case of donating more than 1\.5 liters of blood in the 10 months prior the start
- •of this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Oxytocin TrialAutism Spectrum DisorderMedDRA version: 20.0Level: LLTClassification code 10003805Term: AutismSystem Organ Class: 100000004873Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2013-003067-59-ITAZIENDA OSPEDALIERA G. BROTZ30
Recruiting
Not Applicable
A human trial to evaluate effects of ginsenoside fortified red ginseng on immune function and fatigue recoveryNot ApplicableKCT0001647Dunsan Korean Medicine Hospital of Daejeon University52
Not yet recruiting
Not Applicable
A single-center, randomized, double-blind, placebo-controlled human trial to evaluate the effect of steamed Panax Ginseng extract on the improvement of blood glucose levelKCT0003494Dunsan Korean Medicine Hospital of Daejeon University52
Completed
Not Applicable
A single-center, randomized, double-blind, placebo-controlled, single ascending dose study to investigate the pharmacokinetics, pharmacodynamic effects, safety and tolerability of single doses of RO5459072 in healthy volunteers.Lupus10003816NL-OMON41854F. Hoffmann-La Roche Ltd.16
Recruiting
Phase 1
A single-center, randomized, double-blind, placebo-controlled, dose escalation study to observe the safety and efficacy of catalpol tablets in Chinese healthy subjects.diabetesITMCTR1900002878The First Affiliated Hospital, Zhejiang University